treatment
-
COVID-19
Coronavirus patients rush to join treatment studies: ‘I would enroll my family in a heartbeat’
April 6, 2020 / Marilynn Marchione, Associated Press The new coronavirus made Dr. Jag Singh a patient at his own…
Read More » -
COVID-19
Coronavirus patients in Houston hospital becoming first in US to try experimental plasma transfusion
March 30, 2020 / By Chris Ciaccia | Fox News A Houston-area hospital became the first hospital in the U.S. to transfuse…
Read More » -
COVID-19
Experimental coronavirus treatment using antiviral remdesivir expanded by developer Gilead
March 30, 2020 / By James Rogers | Fox News Biotech company Gilead Sciences is expanding access to its antiviral drug remdesivir as…
Read More » -
Biologics
FDA says it is expediting the use of a blood plasma treatment as New York begins to roll out new clinical trials
March 25, 2020 / By Kara Scannell and Brynn Gingras, CNN (CNN) – The US Food and Drug Administration on Tuesday said it is expediting…
Read More » -
COVID-19
Aetna to cover cost of coronavirus hospital treatment for many members
March 25, 2020 / By Tami Luhby, CNN (CNN) – Many Aetna policyholders will not have to pay for coronavirus treatment if they…
Read More » -
COVID-19
Scientists chase two fronts in how to treat coronavirus, but ‘there’s no magic drug right now’
Elizabeth Weise / USA TODAY SAN FRANCISCO – Doctors and scientists are working furiously to find effective treatments for the illness…
Read More » -
COVID-19
Coronavirus: Combination of antimalarial medication and antibiotics could shorten COVID-19, researchers say
March 20, 2020 / By James Rogers | Fox News A study in France suggests that treating COVID-19 patients with antimalarial medication…
Read More » -
COVID-19
Johnson & Johnson Says There’s Insufficient Evidence Its HIV Drug Can Treat COVID-19
March 16, 2020 / David Jagielski Johnson & Johnson (NYSE:JNJ) released a statement on Monday that said there wasn’t sufficient evidence to…
Read More » -
Hospitals
U.S. hospitals see first decline in outpatient visits since 1983
TARA BANNOW / January 7, 2020 For the first time in 35 years, U.S. hospitals delivered fewer outpatient visits in…
Read More » -
OSN Premium
Study: High Surgeon Satisfaction Using Patient Decision Aids
by Elizabeth Hofheinz, M.P.H., M.Ed., October 11, 2019 In examining 1,220 pre-visit and 967 post-visit surveys, a team of researchers…
Read More » -
OSN Premium
The Challenges of Spine Education and the “Dark Side” of Spine Surgery
by Elizabeth Hofheinz, M.P.H., M.Ed., September 5, 2019 A surgeon’s brain contains much, to be sure…and sometimes, it holds a…
Read More » -
Biologics
Regenerative Medicine Has a Bright Future
Written by Patrick Keeffe | February 10, 2017 U.S. Army scientists, working with medical technology companies, have successfully tested and used…
Read More » -
Sports Medicine
Intralink-Spine’s Réjuve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study
January 31, 2017 – LEXINGTON, Ky.–(BUSINESS WIRE)– With extremely positive clinical results at the six-month juncture from its early safety…
Read More » -
Spine
SpinalCyte, LLC Enrolls First Patient in Landmark Phase I Human Clinical Trial
January 26, 2017 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc…
Read More » -
Biologics
Early data demonstrate motor function improvement for spinal cord stem cell treatment
26th January 2017 A new therapy to treat spinal cord injuries in people who have lost all motor and sensory…
Read More »